Imagent is a drug owned by Vesselon Spv Llc. It is protected by 9 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 25, 2015. Details of Imagent's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5798091 | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
Aug, 2015
(9 years ago) |
Expired
|
| US5720938 | Systems for the formation of microbubbles |
Feb, 2015
(9 years ago) |
Expired
|
| US5695741 | Stable microbubble precursors |
Dec, 2014
(10 years ago) |
Expired
|
| US5639443 | Stabilized microbubble compositions |
Jun, 2014
(10 years ago) |
Expired
|
| US5626833 | Ultrasound imaging method using microbubbles |
May, 2014
(10 years ago) |
Expired
|
| US5605673 | Stabilized microbubble compositions for ultrasound |
Feb, 2014
(10 years ago) |
Expired
|
| US6280705 | Kits & systems for ultrasonic imaging |
Jul, 2013
(11 years ago) |
Expired
|
| US6280704 | Ultrasonic imaging system utilizing a long-persistence contrast agent |
Jul, 2013
(11 years ago) |
Expired
|
| US6287539 | Methods of imaging using osmotically stabilized microbubble preparations |
Jul, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Imagent is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Imagent's family patents as well as insights into ongoing legal events on those patents.
Imagent's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Imagent's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 25, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Imagent Generics:
There are no approved generic versions for Imagent as of now.
About Imagent
Imagent is a drug owned by Vesselon Spv Llc. It is used for medical imaging purposes. Imagent uses Dimyristoyl Lecithin; Perflexane as an active ingredient. Imagent was launched by Vesselon Spv Llc in 2002.
Approval Date:
Imagent was approved by FDA for market use on 31 May, 2002.
Active Ingredient:
Imagent uses Dimyristoyl Lecithin; Perflexane as the active ingredient. Check out other Drugs and Companies using Dimyristoyl Lecithin; Perflexane ingredient
Treatment:
Imagent is used for medical imaging purposes.
Dosage:
Imagent is available in injectable form for intravenous use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.92MG/VIAL;0.092MG/VIAL | INJECTABLE | Discontinued | INTRAVENOUS |